Skip to content
HCN Grants Est. 2026
No. HT942526MRPMASA · Defense Health Agency Contracting Activity - DHACA
Open

DoW Melanoma Research Program Melanoma Academy Scholar Award

Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated

At a glance

The program funds early-career independent investigators to join the Melanoma Academy and pursue melanoma research with a Career Guide. Applications must address at least one FY26 melanoma focus area, including prevention and interception, rare melanomas, or survivorship, and preliminary data are not required. U.S. Department of War organizations may apply, including foreign and domestic, for-profit and nonprofit, and public or private entities; the award is made to organizations, not individuals. The agency expects to fund about two awards totaling roughly $1.54 million, with a maximum of $0.77 million per award and a 3-year period of performance. Cost sharing is not required, and non-melanoma skin cancer studies are not allowed.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Training, Fellowship & Career Development
  • Researchers & Scholars
  • Biomedical & Disease Research
Official description from grants.gov

Summary: Supports the addition of independent, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful, highly productive melanoma researchers in a collaborative research and career development environment. Distinctive Features: This award mechanism focuses on both the Scholar’s research and career potential in the melanoma field. Scholars must designate a Career Guide. The Career Guide must have a track record of successful mentorship coupled with a strong record of funding and publications in melanoma. Preliminary data are not required.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide